1-Cyclopropylpiperazine → HCID 58234951, compound
Reaction equation
N1(C2C[CH2:9][N:8]([CH2:11][C:12]3[S:13][C:14]4[N:15]=[C:16]([Cl:27])[N:17]=[C:18]([N:21]5[CH2:26][CH2:25][O:24][CH2:23][CH2:22]5)[C:19]=4[N:20]=3)CC2)CCC1.[CH:28]1([N:31]2[CH2:36]CN[CH2:33][CH2:32]2)[CH2:30][CH2:29]1>>[Cl:27][C:16]1[N:17]=[C:18]([N:21]2[CH2:26][CH2:25][O:24][CH2:23][CH2:22]2)[C:19]2[N:20]=[C:12]([CH2:11][N:8]3[CH2:33][CH2:32][N:31]([CH:28]4[CH2:30][CH2:29]4)[CH2:36][CH2:9]3)[S:13][C:14]=2[N:15]=1Participants
3
Procedure
Prepared according to the method used in the preparation of 2-(4-azetidin-1-ylpiperidin-1-ylmethyl)-5-chloro-7-morpholin-4-ylthiazolo[5,4-d]pyrimidine using 1-cyclopropylpiperazine in place of 4-azetidin-1-ylpiperidine. The title compound was obtained as a white solid (117 mg, 56%).
Workup
- customPrepared
Sources & evidence
- ORD record
- ord-489d5af4c3b6458dba214de919863534
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893060B2
Reaction notes
Loading…